CT scan vs. needle biopsy: which is better for spotting pancreatic cancer?

NCT ID NCT07424456

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will compare two methods—triphasic CT scans and endoscopic ultrasound-guided biopsies—to see which one more accurately tells benign from malignant pancreatic lesions. Researchers will enroll 50 adults with pancreatic lesions found on initial imaging. The goal is to determine if the less invasive CT scan can match the accuracy of a biopsy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could show that a CT scan is as accurate as a biopsy for diagnosing pancreatic lesions, potentially reducing the need for invasive procedures.

What could go wrong

This is a small, early study with only 50 participants, so results may not apply to everyone. The CT scan might still miss some cancers that a biopsy would catch.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EUS GUIDED BIOPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••